MNKD MannKind Corporation

MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) announced today that the Company will present at the Rodman & Renshaw 18th Annual Global Investment Conference on Monday, September 12, 2016 at 11:40 AM (ET) at the Lotte New York Palace in New York.Presenting from the Company will be its Chief Executive Officer, Matthew J. Pfeffer.Interested parties can access a link to the live webcast of the presentation from the News & Events section of the Company's website at http://www.mannkindcorp.com. About MannKind Corporation MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes.  MannKind maintains a website at http://www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website..

Company Contact:
Rose Alinaya
SVP, Finance
661-775-5300
ralinaya@mannkindcorp.com